• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验设计对预测体细胞突变状态的 PET 影像组学的影响。

Impact of experimental design on PET radiomics in predicting somatic mutation status.

机构信息

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

出版信息

Eur J Radiol. 2017 Dec;97:8-15. doi: 10.1016/j.ejrad.2017.10.009. Epub 2017 Oct 9.

DOI:10.1016/j.ejrad.2017.10.009
PMID:29153372
Abstract

PURPOSE

PET-based radiomic features have demonstrated great promises in predicting genetic data. However, various experimental parameters can influence the feature extraction pipeline, and hence, Here, we investigated how experimental settings affect the performance of radiomic features in predicting somatic mutation status in non-small cell lung cancer (NSCLC) patients.

METHODS

348 NSCLC patients with somatic mutation testing and diagnostic PET images were included in our analysis. Radiomic feature extractions were analyzed for varying voxel sizes, filters and bin widths. 66 radiomic features were evaluated. The performance of features in predicting mutations status was assessed using the area under the receiver-operating-characteristic curve (AUC). The influence of experimental parameters on feature predictability was quantified as the relative difference between the minimum and maximum AUC (δ).

RESULTS

The large majority of features (n=56, 85%) were significantly predictive for EGFR mutation status (AUC≥0.61). 29 radiomic features significantly predicted EGFR mutations and were robust to experimental settings with δ<5%. The overall influence (δ) of the voxel size, filter and bin width for all features ranged from 5% to 15%, respectively. For all features, none of the experimental designs was predictive of KRAS+ from KRAS- (AUC≤0.56).

CONCLUSION

The predictability of 29 radiomic features was robust to the choice of experimental settings; however, these settings need to be carefully chosen for all other features. The combined effect of the investigated processing methods could be substantial and must be considered. Optimized settings that will maximize the predictive performance of individual radiomic features should be investigated in the future.

摘要

目的

基于 PET 的放射组学特征在预测遗传数据方面显示出巨大的潜力。然而,各种实验参数会影响特征提取流程,因此,本研究旨在探讨实验设置如何影响放射组学特征在预测非小细胞肺癌(NSCLC)患者体细胞突变状态中的性能。

方法

我们的分析纳入了 348 名接受过体细胞突变检测和诊断 PET 成像的 NSCLC 患者。对不同体素大小、滤波器和 bin 宽度的放射组学特征提取进行了分析。共评估了 66 个放射组学特征。使用受试者工作特征曲线下面积(AUC)评估特征预测突变状态的性能。通过最小和最大 AUC 之间的相对差异(δ)来量化实验参数对特征可预测性的影响。

结果

绝大多数特征(n=56,85%)对 EGFR 突变状态具有显著的预测能力(AUC≥0.61)。29 个放射组学特征显著预测 EGFR 突变,并且对实验设置具有鲁棒性,δ<5%。所有特征的总体影响(δ)分别为体素大小、滤波器和 bin 宽度的 5%至 15%。对于所有特征,没有一个实验设计可以预测 KRAS+和 KRAS-(AUC≤0.56)。

结论

29 个放射组学特征的预测能力对实验设置的选择具有鲁棒性;然而,对于所有其他特征,需要仔细选择这些设置。所研究的处理方法的综合影响可能很大,必须予以考虑。未来应研究优化设置,以最大限度地提高个体放射组学特征的预测性能。

相似文献

1
Impact of experimental design on PET radiomics in predicting somatic mutation status.实验设计对预测体细胞突变状态的 PET 影像组学的影响。
Eur J Radiol. 2017 Dec;97:8-15. doi: 10.1016/j.ejrad.2017.10.009. Epub 2017 Oct 9.
2
Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.非小细胞肺癌中体细胞突变与代谢成像表型之间的关联
J Nucl Med. 2017 Apr;58(4):569-576. doi: 10.2967/jnumed.116.181826. Epub 2016 Sep 29.
3
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.使用多模态成像和机器学习算法的下一代放射基因组学测序预测非小细胞肺癌患者的EGFR和KRAS突变状态
Mol Imaging Biol. 2020 Aug;22(4):1132-1148. doi: 10.1007/s11307-020-01487-8.
4
Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.特征归一化对放射基因组学分析的影响:从非小细胞肺癌PET/CT图像预测EGFR和KRAS突变
Comput Biol Med. 2022 Mar;142:105230. doi: 10.1016/j.compbiomed.2022.105230. Epub 2022 Jan 11.
5
Value of pre-therapy F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.治疗前F-FDG PET/CT影像组学在预测非小细胞肺癌患者表皮生长因子受体(EGFR)突变状态中的价值
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146. doi: 10.1007/s00259-019-04592-1. Epub 2019 Nov 14.
6
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.基于 PET/CT 影像组学特征预测行手术治疗的非小细胞肺癌患者的无病生存。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):207-217. doi: 10.1007/s00259-017-3837-7. Epub 2017 Sep 24.
7
Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.基于 PET/CT 图像预测非小细胞肺癌患者表皮生长因子受体突变的放射组学研究的现状和质量:系统评价。
Br J Radiol. 2021 Jun 1;94(1122):20201272. doi: 10.1259/bjr.20201272. Epub 2021 May 12.
8
Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.利用PET/CT的影像特征评估非小细胞肺癌中的表皮生长因子受体(EGFR)基因突变状态。
Nucl Med Commun. 2019 Aug;40(8):842-849. doi: 10.1097/MNM.0000000000001043.
9
Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?非小细胞肺癌的CT影像组学分析能否预测组织学类型和表皮生长因子受体(EGFR)突变状态?
Medicine (Baltimore). 2019 Jan;98(1):e13963. doi: 10.1097/MD.0000000000013963.
10
Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.基于影像组学的非小细胞肺癌表皮生长因子受体突变亚型预测。
Med Phys. 2019 Oct;46(10):4545-4552. doi: 10.1002/mp.13747. Epub 2019 Aug 20.

引用本文的文献

1
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods.非小细胞肺癌中癌基因突变状态的预测:一项系统综述和荟萃分析,特别关注基于人工智能的方法
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11962-x.
2
Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study.18F-FDG PET/CT上的总病变糖酵解(TLG)作为局部晚期直肠癌新辅助治疗后病理完全缓解的潜在预测指标:一项回顾性研究
Diagnostics (Basel). 2025 Jul 16;15(14):1800. doi: 10.3390/diagnostics15141800.
3
Current AI technologies in cancer diagnostics and treatment.
癌症诊断与治疗中的当前人工智能技术。
Mol Cancer. 2025 Jun 2;24(1):159. doi: 10.1186/s12943-025-02369-9.
4
Radiomics for Predicting Prognostic Factors in Breast Cancer: Insights from Contrast-Enhanced Mammography (CEM).用于预测乳腺癌预后因素的放射组学:基于对比增强乳腺X线摄影(CEM)的见解
J Clin Med. 2024 Oct 29;13(21):6486. doi: 10.3390/jcm13216486.
5
Mitigating the impact of image processing variations on tumour [F]-FDG-PET radiomic feature robustness.减轻图像处理变化对肿瘤 [F]-FDG-PET 放射组学特征稳健性的影响。
Sci Rep. 2024 Jul 15;14(1):16294. doi: 10.1038/s41598-024-67239-8.
6
New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review.18F-FDG PET/CT 影像组学在肺腺癌表皮生长因子受体(EGFR)突变预测中的新研究进展:综述
Front Oncol. 2023 Nov 29;13:1242392. doi: 10.3389/fonc.2023.1242392. eCollection 2023.
7
Ability of F-FDG Positron Emission Tomography Radiomics and Machine Learning in Predicting KRAS Mutation Status in Therapy-Naive Lung Adenocarcinoma.¹⁸F-氟脱氧葡萄糖正电子发射断层扫描影像组学及机器学习预测初治肺腺癌KRAS突变状态的能力
Cancers (Basel). 2023 Jul 19;15(14):3684. doi: 10.3390/cancers15143684.
8
How Radiomics Can Improve Breast Cancer Diagnosis and Treatment.放射组学如何改善乳腺癌的诊断与治疗
J Clin Med. 2023 Feb 9;12(4):1372. doi: 10.3390/jcm12041372.
9
Impact of Aggregation Methods for Texture Features on Their Robustness Performance: Application to Nasopharyngeal F-FDG PET/CT.纹理特征聚合方法对其稳健性能的影响:在鼻咽部F-FDG PET/CT中的应用
Cancers (Basel). 2023 Feb 1;15(3):932. doi: 10.3390/cancers15030932.
10
Using stacked deep learning models based on PET/CT images and clinical data to predict EGFR mutations in lung cancer.使用基于PET/CT图像和临床数据的堆叠深度学习模型来预测肺癌中的表皮生长因子受体(EGFR)突变。
Front Med (Lausanne). 2022 Oct 10;9:1041034. doi: 10.3389/fmed.2022.1041034. eCollection 2022.